轉(zhuǎn)化生長因子β調(diào)節(jié)蛋白1抗體 返回列表頁

轉(zhuǎn)化生長因子β調(diào)節(jié)蛋白1抗體

英文名稱 TBRG1
中文名稱 轉(zhuǎn)化生長因子β調(diào)節(jié)蛋白1抗體
別    名 NIAM; Nuclear interactor of ARF and Mdm2; Transforming growth factor beta regulator 1; TBRG1; TBRG-1; TBRG 1; Transforming growth factor beta regulator 1.
 
說 明 書 0.2ml  
研究領(lǐng)域 腫瘤  細(xì)胞生物  免疫學(xué)  染色質(zhì)和核信號  細(xì)胞周期蛋白  
抗體來源 Rabbit
克隆類型 Polyclonal
交叉反應(yīng) Human, Mouse, Rat, Dog, Pig, Cow, Horse, Rabbit, 
產(chǎn)品應(yīng)用 WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500 （石蠟切片需做抗原修復(fù)） 
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
分 子 量 45kDa
細(xì)胞定位 細(xì)胞核 
性    狀 Lyophilized or Liquid
濃    度 1mg/1ml
免 疫 原 KLH conjugated synthetic peptide derived from human TBRG1
亞    型 IgG
純化方法 affinity purified by Protein A
儲 存 液 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
保存條件 Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.

PubMed PubMed
產(chǎn)品介紹 background:
Acts as a growth inhibitor. Can activate TP53/p53, causes G1 arrest and collaborates with CDKN2A to restrict proliferation, but does not require either protein to inhibit DNA synthesis. Redistributes CDKN2A into the nucleoplasm. Involved in maintaining chromosomal stability. There are two isoforms.

Function:
Acts as a growth inhibitor. Can activate p53/TP53, causes G1 arrest and collaborates with CDKN2A to restrict proliferation, but does not require either protein to inhibit DNA synthesis. Redistributes CDKN2A into the nucleoplasm. Involved in maintaining chromosomal stability.

Subunit:
Interacts with CDKN2A and MDM2.

Subcellular Location:
Nucleus.

Tissue Specificity:
Widely expressed at low levels in most tissues, with highest levels in pancreas, lung and liver. Expression is decreased in primary tumors including lung, liver, breast, pancreas and kidney carcinomas, chronic lymphocytic leukemia and diffuse large B-cell lymphoma.xy-0874R    DEKDEK癌基因結(jié)合蛋白
xy-12138R    DLGAP1PSD95結(jié)合蛋白1抗體
xy-12139R    DLGAP2PSD95結(jié)合蛋白2抗體
xy-12140R    DLGAP4PSD95結(jié)合蛋白4抗體
xy-7065R    DPF2雙PHD-D4鋅指蛋白2抗體
xy-7066R    DUSP22雙特異性磷酸酶22抗體
xy-1276R    DNAJC10Erdj5/DNAJC10蛋白抗體
xy-7678R    DR6腫瘤細(xì)胞調(diào)亡素/腫瘤壞死因子受體死亡受體6抗體
xy-9427R    TMIGD1跨膜TMIGD1蛋白抗體
xy-11024R    DNAI1 + 2軸絲中鏈動力蛋白抗體
xy-11023R    DNAH7軸絲動力蛋白7抗體
xy-11778R    DORFIN環(huán)指蛋白19抗體
xy-11679R    delta 2 Cateninδ-連環(huán)蛋白抗體
xy-4307R    beta 2 Defensin防御素β2抗體
xy-11044R    phospho-DAB2 (Ser24)磷酸化信號轉(zhuǎn)導(dǎo)功能磷蛋白DAB2抗體
xy-11431R    DUOX1雙氧化酶1/甲狀腺氧化酶1抗體
xy-11432R    DUOX2雙氧化酶2/甲狀腺氧化酶2抗體
xy-11433R    DUOXA1雙氧化酶成熟因子抗體
xy-11825R    DOCK7胞質(zhì)分裂專一蛋白7抗體
xy-6376R    DDIT4LDNA損傷誘導(dǎo)轉(zhuǎn)錄樣蛋白4抗體
xy-7625R    DAP3死亡相關(guān)蛋白3抗體
xy-7129R    Defensin alpha 6防御素α6抗體
xy-5748R    DBF4BS期激酶活化蛋白DBF4B抗體
xy-5749R    DCK脫氧胞苷激酶抗體
xy-2286R    DHRS3短鏈脫氫還原酶3抗體
xy-13022R    DNA Polymerase theta/POLHDNA聚合酶θ/DNA pol θ抗體
xy-9668R    DENND2DDENN域內(nèi)含蛋白2D抗體
xy-5152R    Alpha Dystroglycan肌萎縮相關(guān)蛋白DAG1抗體
xy-4075R    phospho-DAG1 (Tyr892)磷酸化肌萎縮相關(guān)蛋白DAG1抗體
xy-5303R    phospho-DAAM1 (Thr361)磷酸化形態(tài)發(fā)生紊亂關(guān)聯(lián)激活因子1抗體